Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by MSvantonon May 17, 2018 3:54pm

81 Views

Post# 28048330

RE:RE:Could pullback a bit but we have fundamentals

Do you agree with me now? - no pullback - tomorrow will be even better - too much going on here - Health Canada meeting and big better financials - and of course the best news ever today -Theralase's patient No. 6 free of bladder cancer - the penny days are going to be a thing in the past - welcome dollar days - GL ALL

MSvanton wrote: Not going to happen - there will be the day traders that get in and out - the penny flippers will scare people to thinking its heading down - news didn't get out properly for this - its coming out now - word spreading - wait until tomorrow when the news sits overnight to new ears - this is only heding north - GL

bencro wrote: Pullback would be brief though, if there's one. Watch for 0.26-0.27$. But because we now have solid (but still limited) human data, overall, we should keep strength.